ImmunoCellular (IMUC) Plans Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/11/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- AppLovin gains market share among e-commerce advertisers
- Wall Street ends higher as investors turn to earnings season
ImmunoCellular (IMUC) Slammed on Common, Warrants Pricing
October 18, 2012 9:47 AM EDTImmunoCellular Therapeutics, Ltd. (AMEX: IMUC) shares are getting slammed Thursday following the announced pricing of a common stock and warrants offering. Shares are down about 17 percent early.
From the release:
[ImmunoCellular Therapeutics] has priced an underwritten public offering of an aggregate of 10,000,000 shares of its... More
